Medpace Holdings, Inc. logo MEDP - Medpace Holdings, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 6
HOLD 12
SELL 1
STRONG
SELL
0
| PRICE TARGET: $498.86 DETAILS
HIGH: $582.00
LOW: $400.00
MEDIAN: $484.00
CONSENSUS: $498.86
UPSIDE: 15.26%

About Medpace Holdings, Inc. (https://www.medpace.com)

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Key Executives

NAME TITLE DOB SALARY
August James Troendle Chairman & Chief Executive Officer 1956 $1,443,767 USD
Susan E. Burwig Executive Vice President of Operations 1963 $1,223,739 USD
Stephen Ewald Chief Compliance Officer, General Counsel & Corporate Secretary 1969 $1,019,657 USD
Jesse J. Geiger President 1974 $896,367 USD
Kevin Brady Chief Financial Officer & Treasurer 1975 $646,145 USD
Brandon Ebken Chief Information Officer
John T. Wynne Senior Vice President of Commercial Operations & Clinical Pharmacology Unit
Lauren Morris Associate Director of Investors Relations
Todd Meyers Vice President of Business Development & Marketing
Weimin Gai Senior Vice President of Biometrics

Company Peers

Peer analysis pending, check back in 1-2 minutes.